- Home
- / Vittoria Biotherapeutics
Vittoria Biotherapeutics
Total Funding
$25 M
Vittoria Biotherapeutics Summary
Company Summary
- Overview
- Vittoria Biotherapeutics is a company that develops CAR-T cell therapies. It offers Senza5, a proprietary modular platform technology to deliver anti-tumor properties for liquid and solid tumors and T-cell lymphoma treatment.
- Type
- Private
- Status
- Active
- Founded
- 2021
- HQ
- Philadelphia, PA, US | view all locations
- Website
- https://vittoriabio.com/
- Sectors
Table of Contents
Key People
Nicholas Siciliano, Chief Executive Officer, Co-Founder & Director
Aditya Nimmagadda, Sr. Director, CMC
Steven Yang, Director, Laboratory Operations
LocationsView all
1 location detected
Philadelphia, PA HQ
United States
3675 Market St #200